Blog Post Explores Global Fund’s Efforts To Control Malaria, Address Drug Resistance Globally

Friends of the Global Fight: How the Global Fund Is Responding to Resistance Threats in Malaria Control
In this blog post, the second in a series of posts exploring the threat that drug resistance poses in addressing the HIV/AIDS, TB, and malaria, Anna Carroll, intern, and Mark P. Lagon, chief policy officer, both with Friends of the Global Fight, discuss efforts to control malaria and address drug resistance. The authors write, “The Global Fund’s goal to eliminate malaria from the Greater Mekong subregion is the sort of bold action that is needed to counter the tremendous threat posed by drug resistance. Without this ambitious programming, insecticide- and drug-resistant strains will continue to spread, jeopardizing the significant progress that has been made in the fight against malaria. Continued U.S. leadership can act as a catalyst for more funding commitments to the Global Fund, which can help stop the spread of disease and save millions of people at risk of malaria worldwide” (11/29).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.